☆ 4.5 Letter

Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival

BONE MARROW TRANSPLANTATION (2019)

Get Full Text
Add to Collection

Journal

BONE MARROW TRANSPLANTATION
Volume 54, Issue 9, Pages 1518-1520

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41409-019-0493-5

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Funding

  1. A. Alfred Taubman Medical Research Institute
  2. Edith S. Briskin/Shirley K Schlafer Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.